Review of the Most Important Presentations from the 2019 San Antonio Breast Cancer Symposium

February 7, 2020

This program will provide a comprehensive review of the most important presentations from the 2019 San Antonio Breast Cancer Symposium.

 

Presentations will not be printed. A copy of presentation slides can be accessed via UPMC MyCloud. Instructions on how to access program slides will be emailed to the email address that was provided during online registration.

Target Audience

Physicians, researchers, advanced practice providers, nurses, and other health care professionals who work with individuals with breast cancer.

 

Learning Objectives

Upon completion of this program, attendees will be able to:

  • Identify the most up to date findings in breast cancer clinical and translational research.
  • Incorporate research findings to appropriately manage patients with breast cancer.
  • Demonstrate understanding of the scientific findings in breast cancer research by demonstrating competence in the clinical setting.

Additional Information

Course summary
Available credit: 
  • 6.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.75 Attendance
Course opens: 
12/12/2019
Course expires: 
12/31/2020
Event starts: 
02/07/2020 - 8:00am
Event ends: 
02/07/2020 - 5:00pm
Cost:
$1.00

 

8:00 am

 

Welcome- Shannon Puhalla, MD

 

12:10 pm

 

Lunch

 

8:15 am

 

Genomics- Adrian Lee, PhD

 

12:30 pm

 

Tumor Board (3 cases) moderator: Dhaval Mehta, MD

 

 

8: 30 am

 

Questions & Answers

 

1:15 pm

 

Breast Imaging Update - Uzma Waheed

 

8:35 am

 

Immunotherapy Update- Leisha Emens, MD, PhD

 

1:35 pm

 

Surgery Update – Priscilla McAuliffe, MD, PhD, FACS

Mia Diego, MD

 

8:55 am

 

BRAC related cancer- Shannon Puhalla, MD

 

2:00 pm

 

Radiation Oncology Update - John Austin Vargo, MD

 

9:10 am

 

Questions & Answers

 

2:20 pm

 

Questions & Answers

 

9:20 am

 

Keynote Speaker- Norman Wolmark - NSABP, past, present, and future

 

2:30 pm

 

Keep in Mind Studies- Terry Evans, MD, FACP

 

10:00 am

 

Questions & Answers

 

2:50 pm

 

Survivorship – Josie van Londen, MD, MSc

10:10 am

 Break

 

3:05

 

Questions & Answers/ Departing Comments

 

10:30 am

 

HER2 Metastatic Update- Adam Brufsky, MD, PhD, FACP

3:30 pm

Adjournment

Herberman Conference Center at UPMC Shadyside
Pittsburgh, PA
United States

COURSE DIRECTORS:


Dhaval Mehta, MD

Clinical Assistant Professor

University of Pittsburgh School of Medicine

UPMC Hillman Cancer Center, Monroeville


Shannon Puhalla, MD

Assistant Professor of Medicine

University of Pittsburgh School of Medicine

UPMC Hillman Cancer Center

UPMC Passavant

Magee-Women's Hospital of UPMC

 

Adam Brufsky, MD, PhD, FACP

Professor of Medicine

University of Pittsburgh School of Medicine

Associate Division Chief Division of Hematology/Oncology

University of Pittsburgh School of Medicine

Medical Director, Magee Women’s Cancer Program

UPMC Hillman Cancer Center

Associate Director for Clinical Investigations

UPMC Hillman Cancer Center

Co-Director, Comprehensive Breast Cancer Center

Magee-Women's Hospital of UPMC

 

Emilia Diego, MD

Assistant Professor

University of Pittsburgh School of Medicine

Magee-Women's Hospital of UPMC

 

Leisha A. Emens, MD PhD

Professor of Medicine

UPMC Hillman Cancer Center/Magee Women's Hospital

Director of Translational Immunotherapy for the Women's Cancer Research Center

Co-Leader, Hillman Cancer Immunology/Immunotherapy Program

 

Terry L. Evans, MD, FACP

Clinical Assistant Professor of Medicine,

University of Pittsburgh School of Medicine

Medical Director of the Arnold Palmer Cancer Center.

 

Vikram Gorantla, MD

Medical Oncologist

UPMC Hillman Cancer Center

 

 

Adrian V. Lee, PhD

Pittsburgh Foundation Endowed Chair in Precision Medicine

Professor of Pharmacology & Chemical Biology

Director, Institute for Precision Medicine

UPMC Hillman Cancer Center

 

Priscilla McAuliffe, MD, PhD, FACS

Assistant Professor of Surgery

University of Pittsburgh School of Medicine

Magee-Women's Hospital of UPMC

 

M. Pervaiz Rahman, MD

Clinical Assistant Professor

University Pittsburgh School of Medicine

UPMC Hillman Cancer Center

 

Priya Rastogi, MD

Senior Associate Medical Director

NSABP Medical Affairs

Associate Professor of Medicine

University of Pittsburgh School of Medicine

UPMC Hillman Cancer Center

 

G. van Londen, MD, MSc

Director, Cancer LiveWell Survivorship Program

UPMC Hillman Cancer Center

Magee-Women's Cancer Program

Rohit Bhargava, M.D.

Professor of Pathology, University of Pittsburgh

Interim Chief of Pathology, Magee-Women's Hospital of UPMC

 

John Austin Vargo, MD

Assistant Professor of Radiation Oncology

Regional Medical Director, Central Region

Magee Women's Hospital of UPMC

 

Uzma Waheed

Assistant Professor,

Department of radiology

University of Pittsburgh school of Medicine

Magee women’s hospital of UPMC

 

Norman Wolmark, MD

Chairman, NSABP

Group Chair and Contact PI, NRG Oncology

Professor of Surgery, University of Pittsburgh

 

 

 

All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

The following relevant financial relationships were disclosed:

  • Adam Brufsky, MD, PhD, MD – Consultant: Puma, Seattle Genetics, Daiichi, Roche, AstraZeneca
  • Adrian V. Lee, PhD – Grant/Research: NIH/NCI, Susan G. Komen, BCRF, PA DOH, Glimmer of Hope, Ocean Genomics; Consultant: Enterprises, Boehringer Ingelheim; Stockholder: Ocean Genomics
  • John Austin Vargo, MD – Other: Clinical Pathways, Elselvier
  • Leisha A. Emens, MD, PhD – Consult Board/Advisory: AbbVie, Amgen, AstraZeneca, Bayer, Bristol Meyers Squibb, Celgene, Chugai, eTheRNA, Genentech, Gritstone, Medimmune, Molecuvax, Marcrogenics, Novartis, Peregrine, Replimune, Roche, Silverback, Syndax, Vaccine; Research Funding: Aduro Biotech, AstraZeneca, Breast Cancer research Foundation, Bristol Meyer Squibb, Corvus, Department of defense EMD Serono, Genentech, HertiX, Inc., Maxcyte, Merck, National Cancer Institute, NSABP Foundation, Roche, Tempest, Translational Breast cancer Research Consortium, Royalty: Aduro IND Licensing/vaccine

EMD Serono, Genentech, HertiX, Inc., Maxcyte, Merck, National Cancer Institute, NSABP Foundation, Roche, Tempest, Translational Breast cancer Research Consortium, Royalty: Aduro IND Licensing/vaccine

  • Shannon Puhalla, MD – Grant/Research: AbbVie, Pfizer, Lilly, Novartis, Incyte, Covariance-Bayer, AstraZeneca, Consultant: AbbVie, MedImmune, Celldex, Puma, Pfizer, AstraZeneca, Esai, nanostring
  • Uzma Waheed, MD – Consultant: Becton Dickinson
  • Priya Rastogi, MD – Other, travel and Accommodations: Lilly/Genentech, AstraZeneca
  • Vikram Gorantla, MD – Consultant: Mylan, IntegraConnect

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.        Acknowledgement of Commercial Support:  Utilize the following statement whenever commercial support has been obtained for this activity.  You may only list a company if a signed letter of agreement and the check have been received.

Accreditation and credit designation

Physicians

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 6.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.75 Attendance

Price

Cost:
$1.00
Please login or register to take this course.

If you plan to attend the conference remotely please register and contact course coordinator Becky McClelland at mcclellandr2@upmc.edu